Gene Salkind's most recent trade in Coeptis Therapeutics Holdings Inc was a trade of 5,700 Non-qualified Stock Options (right to buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coeptis Therapeutics Holdi... | Gene Salkind | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 5,700 | 8,950 | - | - | Non-qualified Stock Options (right to buy) | |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 17 Jan 2025 | 241,229 | 365,127 | - | 2.3 | 550,002 | Common Stock |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 35,000 | 35,000 | - | - | Options to buy common stock | |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 25,000 | 25,000 | - | - | Options to buy common stock | |
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | 30 Dec 2024 | 420,000 | 8,643,695 | - | 0.5 | 210,000 | Common Stock | |
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | 30 Dec 2024 | 210,000 | 411,544 | - | - | Convertible notes | ||
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 250,000 | 831,544 | - | - | Common Stock Options | |
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | 06 Aug 2024 | 7,675,160 | 8,223,695 | - | 0.2 | 1,535,032 | Common Stock | |
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | 06 Aug 2024 | 7,675,160 | 8,223,695 | - | 0.2 | 1,535,032 | Common Stock | |
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | 06 Aug 2024 | 751,973 | 616,201 | - | - | Series H Preferred Stock | ||
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | 06 Aug 2024 | 751,973 | 581,544 | - | - | Series H Preferred Stock | ||
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 50,000 | 8,135,931 | - | - | Convertible Promissory Notes | |
| Mobiquity Technologies Inc... | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 160,000 | 8,035,931 | - | - | Convertible Promissory Notes | |
| Coeptis Therapeutics Holdi... | Salkind Gene | Director | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 05 Jan 2024 | 11,600 | 284,056 | - | 0.7 | 8,004 | Common Stock |
| Mobiquity Technologies Inc | Salkind Gene | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Dec 2023 | 751,973 | 7,615,931 | - | - | Preferred Stock Series H | |
| Mobiquity Technologies Inc | Salkind Gene | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 300,789 | 3,103,990 | - | - | Preferred Stock Series G | |
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 100,000 | 7,715,931 | - | - | Common stock options | |
| Coeptis Therapeutics Holdi... | Gene Salkind | Director | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 25 Aug 2023 | 28,638 | 28,638 | - | 0.9 | 26,061 | Common Stock |
| Coeptis Therapeutics Holdi... | Gene Salkind | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 25 Aug 2023 | 4,006 | 4,046 | - | 1.0 | 4,046 | Common Stock |
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.17 per share. | 12 Apr 2023 | 1,385,663 | 4,478,017 | - | 0.2 | 235,563 | Common Stock |
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.17 per share. | 06 Apr 2023 | 130,000 | 3,092,354 | - | 0.2 | 21,710 | Common Stock |
| Coeptis Therapeutics Holdi... | Gene Salkind | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 30,000 | 30,000 | - | - | Non-qualified Stock Options (right to buy) | |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 50,000 | 50,000 | - | - | Stock Option Grant (right to buy) | |
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | 30 Jun 2022 | 510,000 | 0 | - | - | Notes | ||
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | 30 Jun 2022 | 408,000 | 2,992,354 | - | 1.3 | 510,000 | Common Stock | |
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | 30 Jun 2022 | 204,000 | 1,441,500 | - | - | Warrants | ||
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | 30 Mar 2022 | 1,368,333 | 2,484,354 | - | 1.5 | 2,052,500 | Common Stock | |
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | 30 Mar 2022 | 684,166 | 1,237,500 | - | - | Warrants | ||
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 30 Mar 2022 | 125,000 | 125,000 | - | 4 | 500,000 | Common Stock |
| Mobiquity Technologies Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 35,000 | 1,422,500 | - | - | Common Stock Options | |
| Upexi Inc | Gene Salkind | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 50,000 | 50,000 | - | - | Option Grant |